What Is Refractory Celiac Disease?
For the vast majority of people with celiac disease, a strict gluten-free diet resolves symptoms and allows the intestinal lining to heal. But a small minority — estimated at 1-2% of celiac disease patients — continue to have symptoms and intestinal damage despite genuine strict adherence to a GF diet for more than 12 months. This condition is called refractory celiac disease (RCD).
RCD is a serious condition requiring specialist evaluation and management. This guide explains what it is, why it happens, how it's diagnosed, and what treatment options exist.
Two Types of Refractory Celiac Disease
RCD is classified into two types based on the appearance of intraepithelial lymphocytes (IEL) — immune cells in the intestinal lining — on biopsy.
RCD Type I (RCD-I): The IELs appear normal in surface markers and phenotype. This type is more responsive to treatment and has a better prognosis.
RCD Type II (RCD-II): The IELs are clonal — a single abnormal cell type has expanded, which indicates a pre-malignant process. RCD-II carries a significantly higher risk of progressing to enteropathy-associated T-cell lymphoma (EATL), a serious and difficult-to-treat lymphoma of the small intestine. Five-year survival rates for RCD-II are much lower than for RCD-I.
Distinguishing between RCD-I and RCD-II requires specialized immunohistochemical analysis of biopsy tissue and is performed at celiac disease referral centers.
Before Diagnosing RCD: Rule Out Other Causes
Before concluding that someone has true refractory celiac disease, clinicians must rigorously exclude other explanations for persistent symptoms:
1. Ongoing Gluten Exposure
This is by far the most common reason for persistent celiac disease symptoms. Most people who believe they're following a strict GF diet are experiencing unintentional gluten exposure from:
- Hidden gluten in processed foods
- Cross-contamination at home or in restaurants
- Medications and supplements containing wheat starch
- Certified GF oats (which some celiac patients still react to due to avenin)
Evaluation by a registered dietitian with expertise in celiac disease, performing a detailed dietary analysis, is essential before diagnosing RCD.
Testing that can help identify ongoing exposure:
- tTG-IgA levels (persistent elevation suggests ongoing gluten ingestion)
- 24-hour urine gluten immunogenic peptides (GIP) — a newer test that can detect gluten consumption in the past 24-48 hours
- Stool GIP testing
2. Other Conditions Causing Persistent Symptoms
Several conditions can coexist with celiac disease and cause persistent GI symptoms:
- Small Intestinal Bacterial Overgrowth (SIBO): Very common in celiac disease (occurs in up to 50% of patients with ongoing symptoms). Causes bloating, diarrhea, and malabsorption. Diagnosed with a breath test; treated with antibiotics.
- Microscopic colitis: Inflammation of the large intestine not visible to the naked eye but apparent on biopsy. More common in celiac disease and causes watery diarrhea.
- Exocrine pancreatic insufficiency (EPI): Reduced pancreatic enzyme production, causing fat malabsorption and diarrhea. Can coexist with celiac disease.
- Collagenous sprue: A rare condition causing collagen deposition under the intestinal lining that impairs nutrient absorption.
- IBS-like symptoms: Celiac disease and IBS can coexist. IBS-type symptoms (pain, altered bowel habits, bloating without structural damage) may persist after celiac healing.
- Food intolerances: Secondary lactose intolerance, fructose malabsorption, and fructan sensitivity may persist even after the intestinal lining heals.
Only after all these possibilities have been thoroughly excluded should a diagnosis of true RCD be made.
Symptoms of Refractory Celiac Disease
RCD presents with:
- Persistent diarrhea and malabsorption despite strict GF diet
- Continued weight loss or failure to maintain weight
- Abdominal pain and cramping
- Continued villous atrophy on biopsy after 12+ months of strict GF diet
- Nutritional deficiencies that persist or worsen despite supplementation
- In severe cases: abdominal lymphadenopathy, fever, night sweats (signs of lymphoma in RCD-II)
Treatment of Refractory Celiac Disease
RCD is managed at specialist celiac disease referral centers. Treatment depends on whether it's RCD-I or RCD-II.
RCD-I Treatment
Nutritional support: Correction of deficiencies and, if severe malabsorption, enteral or parenteral nutrition.
Immunosuppressive therapy:
- Budesonide (an oral corticosteroid with primarily local GI effects): First-line treatment, with reasonable response rates in RCD-I
- Azathioprine or 6-mercaptopurine: Immunosuppressants that reduce intestinal inflammation
- Prednisone: Systemic steroids for severe cases
Open-capsule mesalamine: Sometimes used as a topical anti-inflammatory in the small intestine.
RCD-II Treatment
RCD-II is much harder to treat and requires management by specialists in both celiac disease and oncology:
- Cladribine (2-chlorodeoxyadenosine): A chemotherapy agent that has shown effectiveness in reducing the abnormal T-cell clone in RCD-II
- Bone marrow/stem cell transplantation: Considered in select cases as a potentially curative approach
- Anti-IL-15 therapy (AMG 714): In clinical trials; IL-15 is a cytokine implicated in RCD-II pathogenesis
- Intensive monitoring for progression to EATL lymphoma
Prognosis
RCD-I generally responds to treatment and, while chronic, is manageable long-term with immunosuppression and strict dietary adherence.
RCD-II carries a much more guarded prognosis. Approximately 50-60% of RCD-II cases progress to enteropathy-associated T-cell lymphoma within 5 years. This is a rare but serious cancer with poor response to conventional chemotherapy.
Early diagnosis of celiac disease and strict, sustained GF diet adherence is the most effective way to reduce the risk of ever developing RCD. Most cases of RCD that appear to be "true" refractory disease resolve when a celiac-expert dietitian identifies and eliminates previously undetected sources of gluten exposure.